Current Opinion in HIV & AIDS:
Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Françoise Barré-Sinoussi, PhD, is the Director of the “Regulation of Retroviral Infections” Unit in the Department of Virology at the Institut Pasteur in Paris, France. She has been involved in retrovirology research, since the early 1970's. She is recognized for her contributions to HIV/AIDS research, in particular as the first author of the publication that reported in 1983 the discovery of the cause of AIDS, a retrovirus, later named HIV. In 1988, she became responsible of her own laboratory at the Institut Pasteur and initiated research programs on viral and host determinants of HIV/AIDS pathogenesis. She has also been implicated in collaborative programs on HIV vaccine research, using primate models. Today, the research programs of her team are focused on mechanisms required to protect against HIV/SIV infections and/or against early pathogenic signals induced by HIV/SIV (regulation of viral replication and/or regulation of harmful T cell activation, in particular by components of the innate immunity).
Franoise Barr-Sinous...Image Tools
Françoise Barré-Sinoussi has been strongly implicated in promoting integration between HIV/AIDS research and actions in resource limited countries, in particular through the Institute Pasteur International Network and the coordination of the ANRS research programs in Cambodia and Vietnam, according to her strong commitment in building capacity, training and technology transfers on site in Africa and Asia. Françoise Barré-Sinoussi is author and co-author of 270 original publications and of more than 120 articles in book reviews. She has been invited as a speaker more than 270 International meetings and/or conferences. Françoise Barré-Sinoussi has been (and is still) a member of a number of French or international scientific committees and societies, including scientific committees of several international AIDS conferences. In June 2006, Françoise Barré-Sinoussi was elected as an IAS Governing Council member in the European region. Through her career, she received more than 10 national or international awards, including the Nobel Prize for Medicine in 2008 together with Prof. Luc Montagnier for her contributions to HIV/AIDS. She was also awarded Doctor honoris causa of a number of universities. In February 2009 she was elected member of the French Academy of Science. Since July 2012 she has been the President of the IAS.
Michael Lederman is the Scott R. Inkley Professor of Medicine at Case Western Reserve University School of Medicine and University Hospitals/Case Medical Center, USA, where he is also Professor of Biomedical Ethics, Pathology, Microbiology and Molecular Biology. Dr Lederman received his bachelor's degree in biology from Brandeis University, USA, and his MD from the Mt. Sinai School of Medicine, USA. He trained in internal medicine at Case Western Reserve University, University Hospitals of Cleveland and the VA Medical Center, USA, where he served as chief resident in medicine and completed fellowship training in infectious diseases. He received post-doctoral training in cellular immunology in the laboratory of Dr Jerrold Ellner and he joined the faculty at Case in 1980. Dr Lederman has been engaged in HIV/AIDS research since he and Dr Oscar Ratnoff first described and characterized the occurrence of AIDS-related immune deficiency in otherwise healthy men with hemophilia in 1983. He has authored more than 300 peer-reviewed scientific publications largely focused on the mechanisms whereby HIV infection induces immune deficiency and on strategies to correct and prevent it. In 1985, Dr Lederman established the Special Immunology Unit at University Hospitals of Cleveland that was the first dedicated HIV clinic in Northern Ohio, USA. In 1987, he established the AIDS Clinical Trials Unit at Case/University Hospitals and within the national network of these units, the AIDS Clinical Trials Group (ACTG), he directs the network of Immunology Service Laboratories that provides immunologic monitoring of national HIV treatment trials and is Chairman of the Inflammation and End Organ Disease Transformative Science Group. Dr Lederman is a member of the Association of American Physicians, the American Association of Immunologists, the Infectious Diseases Society of America, the HIV Medicine Association and is a Fellow of the American Association of Microbiology and the American Association for the Advancement of Science. He serves on the editorial boards of several research journals, and is a member of the Scientific Advisory Boards for the Forum for Collaborative Research and the Agence Nationale de Recherche sur le SIDA (ANRS).
Michael Lederman...Image Tools
© 2013 Lippincott Williams & Wilkins, Inc.